WO2003074004A3 - Method of producing antigens - Google Patents
Method of producing antigens Download PDFInfo
- Publication number
- WO2003074004A3 WO2003074004A3 PCT/US2003/006661 US0306661W WO03074004A3 WO 2003074004 A3 WO2003074004 A3 WO 2003074004A3 US 0306661 W US0306661 W US 0306661W WO 03074004 A3 WO03074004 A3 WO 03074004A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- producing
- antigens
- reactive
- transglutaminase
- cross
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 8
- 102000036639 antigens Human genes 0.000 title abstract 8
- 108091007433 antigens Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 5
- 108060008539 Transglutaminase Proteins 0.000 abstract 4
- 102000003601 transglutaminase Human genes 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000003124 biologic agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003213718A AU2003213718A1 (en) | 2002-03-01 | 2003-03-03 | Method of producing antigens |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36116602P | 2002-03-01 | 2002-03-01 | |
US60/361,166 | 2002-03-01 | ||
US36344502P | 2002-03-08 | 2002-03-08 | |
US60/363,445 | 2002-03-08 | ||
US10/231,063 | 2002-08-28 | ||
US10/231,298 | 2002-08-28 | ||
US10/231,063 US20030224476A1 (en) | 2002-03-01 | 2002-08-28 | Method of producing transglutaminase reactive compound |
US10/231,114 | 2002-08-28 | ||
US10/231,213 US20040001848A1 (en) | 2002-03-01 | 2002-08-28 | Method of producing disease-specific antigens |
US10/231,470 US7101695B2 (en) | 2002-03-01 | 2002-08-28 | Method of producing transglutaminase having broad substrate activity |
US10/231,298 US20030219853A1 (en) | 2002-03-01 | 2002-08-28 | Method of cross-linking a compound |
US10/231,114 US7485438B2 (en) | 2002-03-01 | 2002-08-28 | Method of producing polyvalent antigens |
US10/231,470 | 2002-08-28 | ||
US10/231,213 | 2002-08-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003074004A2 WO2003074004A2 (en) | 2003-09-12 |
WO2003074004A3 true WO2003074004A3 (en) | 2006-08-10 |
Family
ID=27792403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/006661 WO2003074004A2 (en) | 2002-03-01 | 2003-03-03 | Method of producing antigens |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003213718A1 (en) |
WO (1) | WO2003074004A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
US8961544B2 (en) | 2010-08-05 | 2015-02-24 | Lifebond Ltd. | Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
US9017664B2 (en) | 2006-12-15 | 2015-04-28 | Lifebond Ltd. | Gelatin-transglutaminase hemostatic dressings and sealants |
US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070172496A1 (en) * | 2004-01-28 | 2007-07-26 | Curix Aps | Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
TW200726482A (en) * | 2005-06-30 | 2007-07-16 | Merck & Co Inc | Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
KR101439828B1 (en) | 2005-11-30 | 2014-09-17 | 애브비 인코포레이티드 | Monoclonal antibodies against amyloid beta protein and uses thereof |
JP2010500886A (en) * | 2006-08-18 | 2010-01-14 | ノボ ノルディスク ヘルス ケア アーゲー | Transglutaminase variants with improved specificity |
WO2008102008A1 (en) * | 2007-02-22 | 2008-08-28 | Novo Nordisk Health Care Ag | Transglutaminase variants with improved specificity |
WO2009153751A2 (en) * | 2008-06-18 | 2009-12-23 | Lifebond Ltd | A method for enzymatic cross-linking of a protein |
CN104031393B (en) | 2008-06-18 | 2017-08-01 | 生命连结有限公司 | Improved cross-linked composition |
CA2782863A1 (en) | 2009-12-22 | 2011-06-30 | Lifebond Ltd | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4544638A (en) * | 1984-05-18 | 1985-10-01 | The Regents Of The University Of California | Synthesis of cross-links in the helical domain of collagen using pyridoxal 5-phosphate and copper or iron |
US6010871A (en) * | 1994-09-29 | 2000-01-04 | Ajinomoto Co., Inc. | Modification of peptide and protein |
-
2003
- 2003-03-03 AU AU2003213718A patent/AU2003213718A1/en not_active Abandoned
- 2003-03-03 WO PCT/US2003/006661 patent/WO2003074004A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4544638A (en) * | 1984-05-18 | 1985-10-01 | The Regents Of The University Of California | Synthesis of cross-links in the helical domain of collagen using pyridoxal 5-phosphate and copper or iron |
US6010871A (en) * | 1994-09-29 | 2000-01-04 | Ajinomoto Co., Inc. | Modification of peptide and protein |
Non-Patent Citations (2)
Title |
---|
DE JONG G.A.H. ET AL: "Purification and substrate specificity of transglutaminase from blood and Streptoverticillium mobaraense", JOUR. AGRIC FOOD CHEM., vol. 49, 2001, pages 3389 - 3393, XP003001875 * |
KAHLEM P. ET AL.: "Peptides containing glutamine repeats as substrates for transglutaminase catalyzed cross-linking: Relevance to diseases of the nervous system", PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 14580 - 14585, XP000918974 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
US9540432B2 (en) | 2005-11-30 | 2017-01-10 | AbbVie Deutschland GmbH & Co. KG | Anti-Aβ globulomer 7C6 antibodies |
US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US9359430B2 (en) | 2006-11-30 | 2016-06-07 | Abbvie Inc. | Abeta conformer selective anti-Abeta globulomer monoclonal antibodies |
US9394360B2 (en) | 2006-11-30 | 2016-07-19 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US9017664B2 (en) | 2006-12-15 | 2015-04-28 | Lifebond Ltd. | Gelatin-transglutaminase hemostatic dressings and sealants |
US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
US8961544B2 (en) | 2010-08-05 | 2015-02-24 | Lifebond Ltd. | Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix |
Also Published As
Publication number | Publication date |
---|---|
AU2003213718A1 (en) | 2003-09-16 |
WO2003074004A2 (en) | 2003-09-12 |
AU2003213718A8 (en) | 2003-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003074004A3 (en) | Method of producing antigens | |
WO2006031560A3 (en) | Process for concentration of antibodies and therapeutic products thereof | |
MX348154B (en) | IL-1ß BINDING ANTIBODIES AND FRAGMENTS THEREOF. | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
MXPA03008715A (en) | Reducing the immunogenicity of fusion proteins. | |
CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
WO2005016962A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2002020569A3 (en) | Mammalian genes; related reagents and methods | |
WO2003017935A3 (en) | Human antibodies specific for interleukin 15 (il-15) | |
WO2004043407A3 (en) | Methods and products for treating staphylococcal infections | |
WO2000053758A3 (en) | Compositions and methods for the treatment of immune related diseases | |
EP2292664A3 (en) | Multispecific deimmunized CD3-binders | |
WO2004076620A3 (en) | Human antibodies specific for interleukin 15 (il-15) | |
DE602005001445D1 (en) | N-TERMINAL MONOPEGYLATED HUMAN GROWTH HORMONE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE | |
DK1682583T3 (en) | Protein complex formation using immunoglobulin fragment and method of preparation thereof | |
WO2002060955A3 (en) | Modified antibodies and methods of use | |
WO2004065417A3 (en) | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture | |
EP0911390A3 (en) | Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease | |
EP1053255A4 (en) | THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF | |
WO2010044889A3 (en) | Torque teno virus (ttv) isolates and compositions | |
DE69930630D1 (en) | B2MICROGLOBULIN FUSION PROTEINS AND HIGH AFFINITY VARIATIONS | |
WO2012075173A3 (en) | Compositions and method for deimmunization of proteins | |
CA2326148A1 (en) | Method for providing glutamine | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
GB0010314D0 (en) | Anti-freeze proteins their production and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |